Ivo Schoots
@ivoschootsnl
Radiologist, Erasmus University Medical Center, Rotterdam, The Netherlands. Prostate cancer. Views my own.
ID: 875735111148425217
16-06-2017 15:21:35
47 Tweet
287 Followers
99 Following
Jelle Barentsz Anwar Padhani Valeria Panebianco Vibeke Løgager Maarten de Rooij Hashim U. Ahmed Baris Turkbey MD Clare Tempany MD European Urology RSNA Busch Center Rianne Engels Israel Bas Philippe PUECH Thanks Anwar Padhani Ivo Schoots @geertvilleirs - great pro & con discussion of bpMRI - a must read for urologists doing TBx as well 🎯
Personalizing #ProstateCancer diagnosis with multivariate risk prediction tools: How should #prostate #MRI be incorporated? #BeyondTheAbstract with Ivo Schoots Erasmus MC and Anwar Padhani Scanner Centre. #ReadNow on UroToday > bit.ly/2Y1I0ej East and North Hertfordshire NHS Trust
Hashim U. Ahmed Andrew Vickers Remember MRI goes beyond providing a target for biopsy. this narrow debate. Size, Stage, PI-RADS score, ADC in the mix. The needle needs to move from the 'blind' model-based to 'personalised'. Le'ts #REIMAGINE PCa risk. Jelle Barentsz Ivo Schoots Baris Turkbey MD Gianluca Giannarini
Please join us for our next online 1-hour case-based #prostate #MRI MDM / tumour board. With guest panelists Ivo Schoots and henk van der poel. Wed June 3 2020 at 7:30pm AEDT (11:30am CET, 5:30am EDT) bit.ly/2Xt24nQ
Many reasons for undiagnosed significant cancer using MRI-approaches. The question to @EuroWeb: Is the solution still systematic biopsy (or focal-saturation)? ISUP is now on board with MRI doi: 10.1097/PAS.0000000000001497 Hashim U. Ahmed Gianluca Giannarini Jelle Barentsz
Radiologists beware, prostate MRI quality impacts extend beyond your diagnostic accuracy; affects urology biopsies. Audit your PIQUAL quality in every case Gianluca Giannarini Jelle Barentsz Caroline Moore Baris Turkbey MD doi.org/10.1016/j.euru…
Just published: Risk‐adapted biopsy decision based on prostate MRI and PSA‐density for enhanced biopsy avoidance in first #ProstateCancer diagnostic work‐up by Ivo Schoots and Anwar R Padhani bit.ly/31ze9eg
Another, prospective, multicenter level 1 study unpinning the MRI-directed PCa diagnosis pathway, with the primary benefit being biopsy avoidance and minimizing GG1 detection. Baris Turkbey MD Hashim U. Ahmed European Association of Urology (EAU) Gianluca Giannarini Andrew Vickers
Great debate: Pros and Cons: Prostate MRI should only be reported by quality-certified radiologists in accredited centres. Philippe PUECH Anwar Padhani
#ECR2023 today: looking forward to hearing from #HarrietThoeny and #NicholasMottet on MRI for population prostate cancer screening. What will be the impact on radiologists? Anwar Padhani @JelleBarentz @LondonProstate European Association of Urology (EAU)
Great #ECR2023 debate with #HarrietThoeny and #NicholasMottet on use of MRI for prostate cancer screening Anwar Padhani Hashim U. Ahmed Ivo Schoots
Throwback Thursday: Analysis of Magnetic Resonance Imaging–directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis buff.ly/2PNM1hk Ivo Schoots Anwar Padhani Jelle Barentsz #prostatecancer #ThrowbackThursday
(Another) Excellent presentation by Anwar Padhani on how to optimise the impacts of prostate MRI pathway 🔝🔝🔝👍🏻👍🏻👍🏻 11th Prostate MRI teaching course Zurich 🇨🇭 European Society of Urogenital Radiology #esur #ESUR #prostasecancer
Fantastic first day of the ESUR European Society of Urogenital Radiology Prostate MRI course in Zurich! with Anwar Padhani and Ivo Schoots among other experts…
Optimising the MRI Pathway Impacts Anwar Padhani Anwar Padhani Controversies in imaging: What to do with PIRADS 3 lesions Ivo Schoots Ivo Schoots Active Surveilliance in prostate cancer for whom? Bernd Hamm
Full room in the hot topic “organised prostate cancer screening”. Excellent speeches from Hein Van Poppel Ivo Schoots #emuc23
EMUC 2023 - ESUI Amazing session on PCa by Hein Van Poppel Ivo Schoots Shonit Punwani David Eldred-Evans & V Panebianco
